Read the most important updates from the WMDA office and notifications to support global collaboration. REDOME Survey Please help the Brazilian Bone Marrow Donor Registry, REDOME, by filling out their survey: here.
Redome has initiated a research plan to evaluate REDOME as part of Brazilian public policy for unrelated hematopoietic stem cell transplants, compared to other international registries. The research's main focus is on sustainability and some financial data are fundamental to performing economic analysis. Join the next Registry Ops & Reg Committee Meeting on 18 April, 2024 The Registry Operations and Regulation Committee will be reviewing the Global Trends Report Questionnaire. Would you like to join and give your input? Click here to register for the upcoming meeting on Thursday, 18 April from 13:00 - 14:00 CET. Find more details here. ------------------------------------------------------------------------------------------------------------------------- WMDA strongly condemns the violence that is occurring in Ukraine, Israel and Gaza. We offer our sympathies to all those who are suffering because of these conflicts. We extend our support to the donor registries and medical centres whose donors and patients are negatively affected by these crises. ------------------------------------------------------------------------------------------------------------------------- | 
Coronavirus (2019-nCoV)A novel coronavirus (currently named 2019-nCoV) emerged in Wuhan, China in December 2019. WHO declared a global health emergency on 30 January 2020, and a number of blood and tissue donor guidelines have been issued - largely based on previous guidelines for SARS-CoV and MERS-CoV. Like SARS and MERS, 2019-nCoV displayed high mortality but low infectivity in the early weeks, with limited person-to-person transmission. However, the epidemic quickly changed to display lower mortality but higher infectivity with increasing evidence of sustained person-to-person transmission. Various public health measures taken at a local or national level are likely to aid and/or complicate donor assessment, while the rapid evolution of the epidemic demands a precautionary yet flexible approach to suitability guidelines.
